Recent Developments in the Biology and Medicinal Chemistry of CDK9 Inhibitors: An Update.

Cyclin-dependent kinase 9 (CDK9), which regulates transcriptional elongation, is an attractive therapeutic target for many cancers, especially for cancers driven by transcriptional dysregulation. I...